In an era when increasing demands are being made on the world’s healthcare services, generic medicines provide a major benefit to society by ensuring patient access to quality, safe and effective medicines while reducing the cost of pharmaceutical care. The International Generic Pharmaceutical Alliance (IGPA) was born as an international network of generic medicines associations, committed to promoting generic medicines and exchanging information worldwide.

The Asia-Pacific Region is of key importance to the generic pharmaceutical industry. It is the location of hundreds of generic manufacturing facilities and strategic export opportunities.  It is also an important source of pharmaceutical ingredients and other raw material inputs for our high-quality, low-cost medicines. As such, IGPA strongly supports efforts to expand trade in the region through the Trans-Pacific Partnership (TPP) negotiations.

The 16th Annual Conference of the International Generic Pharmaceutical Alliance (IGPA) will be held on December 9-11 in Brussels - Belgium.